Dr Yvette Drew is a Clinical Senior Lecturer and Honorary Consultant in Medical Oncology in at the Northern Centre for Cancer Care (NCCC) and the Clinical and Translational Research Institute, Newcastle University. She undertook specialist medical oncology training at the Beatson West of Scotland Cancer Centre, Glasgow and the NCCC. During this time, she was awarded a CRUK-funded PhD fellowship investigating the role of PARP inhibitors in Homologous Recombination deficient ovarian cancer. During her PhD she won a Merit Award for her research from the American Society of Clinical Oncology (ASCO) and was awarded the Medical Sciences Doctoral Prize (Newcastle university, 2013). She has played a key role in both the pre-clinical and clinical development of PARP inhibitors in ovarian cancer. Her current post is split between systemic management of gynaecological cancers and the development of novel therapies through early phase clinical trials. Dr Drew is deputy lead for the Newcastle Experimental Cancer Medicines Centre for early phase clinical trials delivery and member of both the NCRI Ovarian and Endometrial clinical studies sub-groups. Research interests are the targeting DNA repair pathways as treatment for cancer.